Australian company PYC Therapeutics has announced a capital raising of up to $653 million, a scale of funding rarely seen on the Australian Securities Exchange and one that places the Perth-founded biotech among a small group of local life sciences firms able to attract global capital at this magnitude. …
PYC’s capital raise marks one of the largest biotech fundraisings in Australian market history
February 2, 2026 Australian Biotech
Latest Video
Georgia Forrest
New Stories
-
Sandoz adds to vision care options with the listing of biosimilar aflibercept
February 2, 2026 - -
PYC’s capital raise marks one of the largest biotech fundraisings in Australian market history
February 2, 2026 - - Australian Biotech -
Genetic Signatures appoints seasoned life sciences executive as CEO
February 2, 2026 - - Australian Biotech -
EMA decision clears regulatory path for Argenica’s lead stroke drug in Europe
February 2, 2026 - - Australian Biotech -
Recce Pharmaceuticals deepens US partnership to advance burn wound treatment
February 2, 2026 - - Australian Biotech -
Another potential turning point for immunotherapy access in Australia
February 1, 2026 - - Latest News -
An announcement that cost more than the listing, because it would have actually cost something
February 1, 2026 - - Latest News